A pilot study of stenting of autologous saphenous vein on early graft remodelling after coronary artery bypass surgery

ISRCTN ISRCTN77486578
DOI https://doi.org/10.1186/ISRCTN77486578
Secondary identifying numbers PG/96147
Submission date
29/10/2001
Registration date
29/10/2001
Last edited
24/07/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Gianni Angelini
Scientific

Department of Cardiac Surgery
United Bristol Healthcare Trust
Bristol Heart Institute
Bristol Royal Infirmary
Marlborough Street
Bristol
BS2 8HW
United Kingdom

Phone +44 (0)117 928 3145
Email G.D.Angelini@bristol.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymEXTENT-1
Study objectivesBrief summary:
Bypass grafting using leg veins is a very effective surgical treatment for advanced coronary heart disease, although the initial benefits of the operation tend to be lost over the following years. This is because the vein grafts themselves become blocked like the original coronary arteries. Many attempts have been made to prevent these late failures either by variations in surgical technique or by using drugs, however the problem remains. Based on a British Heart Foundation funded collaboration between basic scientists and cardiac surgeons stretching over the past 10 years, a radically new therapy has been devised. This involves wrapping the vein in a stocking-like material during the bypass operation so that it will be continuously supported during its life as a graft. In experimental studies,this has had a dramatic effect in reducing the thickening of the graft wall. The present project will be the first test of the effectiveness of the new technique in man.

Hypothesis:
Application of a highly porous non-restrictive external stent to autologous saphenous veins at the time of implantation of coronary artery bypass grafts will reduce graft thickening and neointima formation and increase lumen size.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPrevention of saphenous vein graft stenosis by the use of an external stent
Intervention1. One group of patients will receive conventional bypass graft surgery with saphenous vein
2. In the second group the saphenous vein will be supported with a polyester made stent
Intervention typeProcedure/Surgery
Primary outcome measureStudy endpoints: Graft wall thickness and luminal size using intravascular ultrasound (IVUS) at time of operation and at follow-up. Wall and luminal volume will be computed from the 3-D reconstructions and compared to values obtained intraoperatively. Final wall and luminal volumes and the changes in these parameters will be compared in stented and unstented grafts. Angiography will be carried out as a necessary adjunct to intravascular ultrasound at follow-up.

Clinical Outcomes: Adverse clinical events, including death, myocardial infarction, bleeding, infections, need for reoperation, recurrence of
symptoms will be recorded.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/03/2005
Completion date30/03/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants40
Key inclusion criteriaPatients undergoing coronary artery bypass surgery
Key exclusion criteria1. Re-do surgery
2. First CABG with an associated procedure
3. Associated valve disease
4. Recent MI (<1 month)
5. Poor ejection fraction (<30%)
6. Diabetes
7. Previous history of inflammatory disease
8. Unwillingness to participate in follow-up
Date of first enrolment01/03/2005
Date of final enrolment30/03/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Cardiac Surgery
Bristol
BS2 8HW
United Kingdom

Sponsor information

British Heart Foundation (UK)
Charity

14 Fitzhardinge Street
London
W1H 6DH
United Kingdom

Phone +44 (0)20 7935 0185
Email research@bhf.org.uk
Website http://www.bhf.org.uk/
ROR logo "ROR" https://ror.org/02wdwnk04

Funders

Funder type

Charity

British Heart Foundation (UK) (PG/96147)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2007 Yes No